Latest News in the pharma Industry

Market News

Sanofi's Xyzal Allergy 24HR approved for OTC use in the US

Sanofi's Xyzal Allergy 24HR approved for OTC use in the US

1 Feb 2017

Xyzal is an oral antihistamine with a proven 24-hour effect.

Read more 
Mylan wins US District Court ruling related to Copaxone 40 mg/mL patents

Mylan wins US District Court ruling related to Copaxone 40 mg/mL patents

31 Jan 2017

Patents in question invalidated based on obviousness.

Read more 
IBA Molecular acquires Mallinckrodt nuclear imaging to create world-class radiopharmaceuticals group

IBA Molecular acquires Mallinckrodt nuclear imaging to create world-class radiopharmaceuticals group

31 Jan 2017

The enlarged business will comprise 21 manufacturing centres and commercial operations across 60 countries.

Read more 
Pharmaceutical packaging market expected to reach $104,882 million by 2022

Pharmaceutical packaging market expected to reach $104,882 million by 2022

31 Jan 2017

Manufacturing projects in eco-friendly and biodegradable packaging, which is expected to surge in near future.

Read more 
Big data on way to enabling 'zero defect' glass tubing

Big data on way to enabling 'zero defect' glass tubing

31 Jan 2017

New perfeXion system, which generates around 100,000 data tags/min, makes an important contribution to quality assurance for downstream post-processing steps at the beginning of the value chain.

Read more 
Rapid emergence of MENA biologics industry sees first ever Biopharma Conference and new venue at CPhI Istanbul 2017

Rapid emergence of MENA biologics industry sees first ever Biopharma Conference and new venue at CPhI Istanbul 2017

30 Jan 2017

Developments in local manufacturing, regulatory strategies, market entry and harmonisation to be debated by MENA leaders and Government.

Read more 
Mobius Power MIX mixing systems bring ease of use to single use

Mobius Power MIX mixing systems bring ease of use to single use

30 Jan 2017

Effectively handles difficult-to-mix pharmaceutical ingredients.

Read more 
Sunovion’s Latuda receives FDA approval to treat adolescents with schizophrenia

Sunovion’s Latuda receives FDA approval to treat adolescents with schizophrenia

30 Jan 2017

First treatment approved in 5 years for adolescents aged 13-17 years with schizophrenia.

Read more 
J&J to acquire Acelion for $30 B with spin-out of new R&D company

J&J to acquire Acelion for $30 B with spin-out of new R&D company

29 Jan 2017

Actelion R&D unit to spin out into standalone company based and listed in Switzerland.

Read more 
Knopp Biosciences receives key patent directed to ion channel activators for brain disorders

Knopp Biosciences receives key patent directed to ion channel activators for brain disorders

27 Jan 2017

Issued claims are directed to a series of orally available small molecules and their use in treating epilepsy, neuropathic pain, and other neurological disorders.

Read more 
FDA approves 72 mcg dose of Linzess for adults with chronic idiopathic constipation

FDA approves 72 mcg dose of Linzess for adults with chronic idiopathic constipation

26 Jan 2017

New dosage strength expected to be available in first quarter of 2017.

Read more 
Endo to axe 90 full-time positions as part of organizational review

Endo to axe 90 full-time positions as part of organizational review

26 Jan 2017

Company expects to invest cost savings in its branded and generics business segments.

Read more